A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get notified once we do.
MONOVISC is a unique achievement for treating osteoarthritis (OA). It's the only single-injection viscosupplement approved for relief of joint pain in all synovial joints. Created by the makers of ORTHOVISC, MONOVISC is specially formulated for a single-injection regimen, giving you enhanced durability in a safe, easy-to-use, single injection.
Joints affected by osteoarthritis typically have lower concentrations of hyaluronic acid in the synovial fluid. As a result, the synovial fluid also has lower viscosity and elasticity than healthy synovial fluid, decreasing its ability to lubricate the joint and absorb shocks. Viscosupplements such as MONOVISC are designed to replace the body's natural hyaluronic acid, providing significant pain relief from the symptoms of osteoarthritis.